Evidence map›Paper›PMID 42828234›Full record

ReviewBiochemia medica2026

Beyond accuracy: how often and in which direction diagnostic tests err.

Farrokh Habibzadeh

Abstract readReview
In one paragraph

Review in Biochemia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Farrokh HabibzadehDepartment of Medical Journalism, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diagnostic tests are commonly evaluated using sensitivity, specificity, predictive values, likelihood ratios, and receiver operating characteristic (ROC) curve analysis. Although essential, these measures do not fully answer two practical questions frequently raised in clinical medicine: how often a test makes mistakes, and whether those mistakes are predominantly false positive or false negative. This article introduces two complementary measures that address these questions: the number needed to misdiagnose (NNM), which expresses the frequency of diagnostic error in intuitive clinical terms, and the misdiagnosis direction index (MDI), which indicates whether errors are mainly false positive or false negative. A weighted MDI is also introduced for unequal clinical harms of errors. Together with conventional indices such as Youden's index, these measures provide a broader framework for interpreting diagnostic performance.

Indexed as

Diagnostic ErrorsDiagnostic Tests, RoutineFalse Negative ReactionsFalse Positive ReactionsHumansROC CurveSensitivity and Specificitybiostatisticsdiagnostic errorsfalse negative reactionsfalse positive reactionssensitivityspecificity

Identifiers

PMID42828234
PMCPMC13631959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.